PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a newly published study in Nature Communications unveiling a powerful new method for ...
StockStory.org on MSN5d
Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services StocksEarnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...
Hosted on MSN11mon
Reasons to Retain PacBio (PACB) Stock in Your Portfolio NowGeneyx and Golden Helix will enable PacBio customers to leverage PacBio HiFi data for disease research with the Revio, Sequel II and IIe sequencing systems. In August 2023, PACB and GeneDx ...
Led by researchers from PacBio, GeneDx, and a global consortium of genomics experts, the study utilizes Paraphase, an informatics tool that, when paired with HiFi long-read sequencing, allows for ...
Pioneering what scientists call "HiFi long-read sequencing," recognized as Nature Methods' method of the year for 2022, Pacific Biosciences (NASDAQ:PACB) develops advanced DNA sequencing systems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback